# DOLUTEGRAVIR SODIUM
> **ANDA209658** · Abbreviated New Drug Application (Generic) · Sponsor: CIPLA LTD · Approved 2018-03-05
## Drug
- **FDA Application Number:** ANDA209658
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DOLUTEGRAVIR SODIUM
- **Generic name:** Dolutegravir Sodium
- **Active ingredients:** DOLUTEGRAVIR SODIUM
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** CIPLA LTD
- **First approval:** 2018-03-05
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209658)
---
*AI Analytics · CC0 1.0*